Subsequently, we conducted MTT and Transwell migration experiments to investigate whether the downregulation of LIMS1 could counteract the inhibitory effects induced by RBMS3 overexpression on colon cancer cells. Here, LIMS1 is linked to malignant colon neoplasm.